Aneta Sokolowska, DPM
Foot & Ankle Surgery · Knoxville, TNNPI 1184243784
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,765 of the $11,083 with a category attached, or 61.0%. 27 manufacturers reported payments, led by Smoky Mountain Surgical LLC at 25.4% of the total. 2025 is the largest year on record at $7,412, 4.3 times the $1,724 reported in 2023.
Across 135 payments — averaging $82.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smoky Mountain Surgical LLC$3K
- Smith+Nephew$3K
- Acumed LLC$1K
- Arthrex$790
- Treace Medical Concepts, Inc.$734
- Stryker$670
- plus $2K from 21 others
What the payments were for
- Travel & lodging$4,31839%
- Food & beverage$6,76561%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smoky Mountain Surgical LLC | 22 | $2,816 |
| Smith+Nephew | 35 | $2,633 |
| Acumed LLC | 5 | $1,093 |
| Arthrex | 9 | $790 |
| Treace Medical Concepts, Inc. | 7 | $734 |
| Stryker | 11 | $670 |
| Coastal Medical Technologies LLC | 4 | $465 |
| Amgen | 5 | $288 |
| Integra Lifesciences Corporation | 4 | $266 |
| Epsfl, LLC | 1 | $201 |
| Paragon 28, Inc. | 3 | $189 |
| Paratek Pharmaceuticals, Inc. | 6 | $175 |
| Seapearl East, Inc | 2 | $164 |
| Convatec Inc. | 2 | $153 |
| Biocomposites Inc | 1 | $103 |
| Reprise Biomedical, Inc. | 3 | $68 |
| DJO, LLC | 2 | $49 |
| AbbVie | 3 | $47 |
| Acera Surgical, Inc. | 2 | $46 |
| Voom Medical Devices, Inc. | 1 | $25 |
| Fidia Pharma USA Inc. | 1 | $22 |
| Vertex | 1 | $18 |
| Solventum Corporation | 1 | $17 |
| Sanara Medtech Inc. | 1 | $13 |
| Trice Medical, Inc. | 1 | $13 |
| Cashflow Solutions, LLC | 1 | $12 |
| Kerecis Limited | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ACUMED$1,337
- PICO$1,294
- Grafix$896
- Versajet$651
- COLLAGENASE SANTYL$651
- Lapiplasty System$591
- GRAFIX PL$251
- Oasis$246
- Stravix$246
- KRYSTEXXA$239
- EASYFUSE$210
- InnovaMatrix AC$129
- INFINITY ADAPTIS$113
- SALVATION$105
- HOFFMANN$105
- VALOR$105
- AUGMENT INJECTABLE$105
- OsteoMed$105
- Stimulan$103
How this compares
$11,083 in reported general payments places this provider in the 75th percentile of 145 foot & ankle surgery providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 12 | $11,791 |
| Gentamicin Sulfate | 44 | $1,088 |
| Ciclopirox | 23 | $973 |
| Doxycycline Monohydrate | 59 | $656 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 20 | $634 |
| Gabapentin | 96 | $592 |
| Ketoconazole | 31 | $440 |
| Mupirocin | 59 | $360 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 54 | $311 |
| Cephalexin | 32 | $225 |
| Ammonium Lactate | 12 | $182 |
| Methylprednisolone | 29 | $169 |
| Pregabalin | 13 | $140 |
| Terbinafine Hcl | 17 | $124 |
| Meloxicam | 61 | $74 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $2,633 | $11,79112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 145 foot & ankle surgery providers in Tennessee.
Other foot & ankle surgery in Knoxville
- Tracy PesutKnoxville$16K
- Derrick RolandKnoxville$10K
- Michael TompkinsKnoxville$8K
- Brady AndersonKnoxville$6K
- Sebastien DemoinyMorristown$210K
- Robert ThompsonMurfreesboro$205K
- Bhekumuzi KhumaloUnion City$201K
- Walter ButlerMemphis$191K
- Chad WebsterCordova$185K
- Christian SmithCordova$153K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.